149 related articles for article (PubMed ID: 19934567)
21. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia.
Isbister CM; Mackenzie PJ; Anderson D; Wade NK; Oger J
Mult Scler; 2003 Dec; 9(6):550-3. PubMed ID: 14664466
[TBL] [Abstract][Full Text] [Related]
22. Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
Maghzi AH; Etemadifar M; Saadatnia M
Eur J Neurol; 2007 Apr; 14(4):403-7. PubMed ID: 17388988
[TBL] [Abstract][Full Text] [Related]
23. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis.
Link J; Fredrikson S; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H
Ann Neurol; 1994 Feb; 35(2):197-203. PubMed ID: 7509140
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and incidence of multiple sclerosis in Panama (2000-2005).
Gracia F; Castillo LC; Benzadón A; Larreategui M; Villareal F; Triana E; Arango AC; Lee D; Pascale JM; Gomez E; Armien B
Neuroepidemiology; 2009; 32(4):287-93. PubMed ID: 19246933
[TBL] [Abstract][Full Text] [Related]
25. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
[TBL] [Abstract][Full Text] [Related]
26. The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis.
Gee JR; Chang J; Dublin AB; Vijayan N
Headache; 2005 Jun; 45(6):670-7. PubMed ID: 15953299
[TBL] [Abstract][Full Text] [Related]
27. Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan.
Hader WJ; Yee IM
Neurology; 2007 Sep; 69(12):1224-9. PubMed ID: 17875910
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of multiple sclerosis in the Canary Islands (Spain): a study on the island of La Palma.
Hernández MA
J Neurol; 2002 Oct; 249(10):1378-81. PubMed ID: 12382152
[TBL] [Abstract][Full Text] [Related]
29. Serum mercury level and multiple sclerosis.
Attar AM; Kharkhaneh A; Etemadifar M; Keyhanian K; Davoudi V; Saadatnia M
Biol Trace Elem Res; 2012 May; 146(2):150-3. PubMed ID: 22068727
[TBL] [Abstract][Full Text] [Related]
30. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.
Grytten N; Glad SB; Aarseth JH; Nyland H; Midgard R; Myhr KM
Neurology; 2006 Jan; 66(2):182-6. PubMed ID: 16434650
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of complex regional pain syndrome in a cohort of multiple sclerosis patients.
Schwartzman RJ; Gurusinghe C; Gracely E
Pain Physician; 2008; 11(2):133-6. PubMed ID: 18354707
[TBL] [Abstract][Full Text] [Related]
32. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
33. The frequency of multiple sclerosis in Italy: a descriptive study in Ferrara.
Granieri E; Tola R; Paolino E; Rosati G; Carreras M; Monetti VC
Ann Neurol; 1985 Jan; 17(1):80-4. PubMed ID: 3985590
[TBL] [Abstract][Full Text] [Related]
34. Multiple sclerosis and diseases of autoimmune or related origin.
Cendrowski W
Mater Med Pol; 1989; 21(4):327-9. PubMed ID: 2489249
[TBL] [Abstract][Full Text] [Related]
35. [Autoimmune diseases and multiple sclerosis].
Alemany-Rodríguez MJ; Aladro Y; Amela-Peris R; Pérez-Viéitez MC; Reyes-Yáñez MP; Déniz-Naranjo MC; Sánchez-Garcia F
Rev Neurol; 2005 May 16-31; 40(10):594-7. PubMed ID: 15926131
[TBL] [Abstract][Full Text] [Related]
36. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.
McKeon A; Lennon VA; Jacob A; Matiello M; Lucchinetti CF; Kale N; Chan KH; Weinshenker BG; Apiwattinakul M; Wingerchuk DM; Pittock SJ
Muscle Nerve; 2009 Jan; 39(1):87-90. PubMed ID: 19086079
[TBL] [Abstract][Full Text] [Related]
37. A population-based survey of multiple sclerosis in Shanghai, China.
Cheng Q; Miao L; Zhang J; Ding SJ; Liu ZG; Wang X; Sun XJ; Zhao ZX; Song YJ; Ding XY; Guo ZL; Yang Y; Chen SD; Jiang GX; Fredrikson S
Neurology; 2007 May; 68(18):1495-500. PubMed ID: 17470752
[TBL] [Abstract][Full Text] [Related]
38. Short-term effects of prolonged fasting on multiple sclerosis.
Saadatnia M; Etemadifar M; Fatehi F; Ashtari F; Shaygannejad V; Chitsaz A; Maghzi AH
Eur Neurol; 2009; 61(4):230-2. PubMed ID: 19176964
[TBL] [Abstract][Full Text] [Related]
39. Increasing prevalence and incidence of multiple sclerosis in northern Japan.
Houzen H; Niino M; Hata D; Nakano F; Kikuchi S; Fukazawa T; Sasaki H
Mult Scler; 2008 Aug; 14(7):887-92. PubMed ID: 18573833
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
Singhal BS; Geeta S; Hundalani SG; Menon S
Neurol India; 2009; 57(4):418-23. PubMed ID: 19770542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
